Effect of repaglinide addition to NPH insulin monotherapy on glycemic control in patients with type 2 diabetes

Diabetes Care. 2001 Oct;24(10):1844-5. doi: 10.2337/diacare.24.10.1844.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Blood Glucose / metabolism*
  • Carbamates / administration & dosage
  • Carbamates / therapeutic use*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Drug Therapy, Combination
  • Female
  • Humans
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / therapeutic use*
  • Insulin, Isophane / administration & dosage
  • Insulin, Isophane / therapeutic use*
  • Male
  • Middle Aged
  • Piperidines / administration & dosage
  • Piperidines / therapeutic use*

Substances

  • Blood Glucose
  • Carbamates
  • Hypoglycemic Agents
  • Piperidines
  • Insulin, Isophane
  • repaglinide